scispace - formally typeset
J

Jason L. Hornick

Researcher at Brigham and Women's Hospital

Publications -  522
Citations -  32496

Jason L. Hornick is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Sarcoma & Medicine. The author has an hindex of 83, co-authored 474 publications receiving 26320 citations. Previous affiliations of Jason L. Hornick include Science Applications International Corporation & University of Southern California.

Papers
More filters
Journal ArticleDOI

Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases.

TL;DR: A subset of IMTs with histologic atypia and/or clinical aggressiveness that were analyzed for clinicopathologic features, outcome, and immunohistochemical expression of anaplastic lymphoma kinase (ALK) and other markers to identify potential pathologic prognostic features found ALK reactivity may be a favorable prognostic indicator in IMT and abdominopelvic IMTs recur more frequently.
Journal ArticleDOI

Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor.

TL;DR: A sustained partial response to the ALK inhibitor crizotinib (PF-02341066, Pfizer) is reported in a patient with ALK-translocated IMT, as compared with no observed activity in another patient without theALK translocation, which support the dependence of ALk-rearranged tumors on AlK-mediated signaling and suggest a therapeutic strategy for genomically identified patients with the aggressive form of this soft-tissue tumor.
Journal ArticleDOI

Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas

Adam Abeshouse, +262 more
- 02 Nov 2017 - 
TL;DR: This large-scale analysis of 206 adult soft tissue sarcomas reveals previously unappreciated sarcoma-type-specific changes in copy number, methylation, RNA, and protein, providing insights into refining Sarcoma therapy and relationships to other cancer types.
Journal ArticleDOI

Neuropathological Features of Covid-19.

TL;DR: brains of patients who died 0 to 32 days after the onset of symptoms of SARS-CoV-2 infection showed hypoxic–ischemic changes but no encephali...
Journal ArticleDOI

Inflammatory myofibroblastic tumours: where are we now?

TL;DR: The clinical, pathological, and molecular genetic features of IMT are examined and an approach to diagnosis and differential diagnosis is discussed, particularly those arising in young patients.